{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:14:16Z","timestamp":1790039656807,"version":"4.0.1"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.semcdb.2011.10.023","type":"journal-article","created":{"date-parts":[[2011,10,26]],"date-time":"2011-10-26T07:01:03Z","timestamp":1319612463000},"page":"51-57","source":"Crossref","is-referenced-by-count":92,"title":["Targeting Eph receptors with peptides and small molecules: Progress and challenges"],"prefix":"10.1016","volume":"23","author":[{"given":"Roberta","family":"Noberini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Lamberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena B.","family":"Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2011.10.023_bib0005","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cell.2008.03.011","article-title":"Eph\u2013ephrin bidirectional signaling in physiology and disease","volume":"133","author":"Pasquale","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nrc2806","article-title":"Eph receptors and ephrins in cancer: bidirectional signalling and beyond","volume":"10","author":"Pasquale","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0015","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1023\/B:AGEN.0000037340.33788.87","article-title":"Eph receptor tyrosine kinases in angiogenesis: from development to disease","volume":"7","author":"Brantley-Sieders","year":"2004","journal-title":"Angiogenesis"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0020","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tcm.2007.03.003","article-title":"Regulation of angiogenesis by Eph\u2013ephrin interactions","volume":"17","author":"Kuijper","year":"2007","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0025","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.2174\/138161207781368594","article-title":"Eph\/ephrin signaling as a potential therapeutic target after central nervous system injury","volume":"13","author":"Du","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ceb.2010.08.005","article-title":"Ephrins and Eph receptors in stem cells and cancer","volume":"22","author":"Genander","year":"2010","journal-title":"Curr Opin Cell Biol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0035","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1073\/pnas.0903328106","article-title":"Glial ephrin-A3 regulates hippocampal dendritic spine morphology and glutamate transport","volume":"106","author":"Carmona","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0040","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature09635","article-title":"Reversing EphB2 depletion rescues cognitive functions in Alzheimer model","volume":"469","author":"Cisse","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0045","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1113\/jphysiol.2010.202366","article-title":"Intramyocardial administration of chimeric ephrinA1-Fc promotes tissue salvage following myocardial infarction in mice","volume":"589","author":"Dries","year":"2011","journal-title":"J Physiol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/nm.2341","article-title":"EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy","volume":"17","author":"Lupberger","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0055","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/nrm1662","article-title":"Eph receptor signalling casts a wide net on cell behaviour","volume":"6","author":"Pasquale","year":"2005","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0060","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/14728222.2011.538682","article-title":"Emerging strategies for EphA2 receptor targeting for cancer therapeutics","volume":"15","author":"Tandon","year":"2011","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0065","doi-asserted-by":"crossref","first-page":"46974","DOI":"10.1074\/jbc.M208495200","article-title":"An ephrin mimetic peptide that selectively targets the EphA2 receptor","volume":"277","author":"Koolpe","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0070","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1074\/jbc.M500363200","article-title":"EphB receptor-binding peptides identified by phage display enable design of an antagonist with ephrin-like affinity","volume":"280","author":"Koolpe","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0075","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.mcn.2003.08.006","article-title":"Targeting the EphA4 receptor in the nervous system with biologically active peptides","volume":"24","author":"Murai","year":"2003","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0080","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1021\/bi1006223","article-title":"Structure\u2013activity relationship analysis of peptides targeting the EphA2 receptor","volume":"49","author":"Mitra","year":"2010","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0085","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1517\/14728222.9.6.1179","article-title":"EphA2 as a target for ovarian cancer therapy","volume":"9","author":"Landen","year":"2005","journal-title":"Expert opinion on therapeutic targets"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0090","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/bc800547c","article-title":"Peptide-functionalized nanogels for targeted siRNA delivery","volume":"20","author":"Blackburn","year":"2009","journal-title":"Bioconjug Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0095","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2407-10-10","article-title":"Chemosensitization of cancer cells by siRNA using targeted nanogel delivery","volume":"10","author":"Dickerson","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0100","first-page":"233","article-title":"A fiber modified adenovirus vector that targets to the EphrinA2 receptor reveals enhanced gene transfer to ex vivo pancreatic cancer","volume":"36","author":"Van Geer","year":"2010","journal-title":"Int J Oncol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0105","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1021\/ja801969b","article-title":"Magnetic nanoparticle\u2013peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells","volume":"130","author":"Scarberry","year":"2008","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0110","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.nano.2009.11.003","article-title":"Selective removal of ovarian cancer cells from human ascites fluid using magnetic nanoparticles","volume":"6","author":"Scarberry","year":"2010","journal-title":"Nanomedicine"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0115","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.neuron.2010.02.016","article-title":"EphA4 signaling in juveniles establishes topographic specificity of structural plasticity in the hippocampus","volume":"65","author":"Galimberti","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0120","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1460-9568.2007.05859.x","article-title":"Regeneration-enhancing effects of EphA4 blocking peptide following corticospinal tract injury in adult rat spinal cord","volume":"26","author":"Fabes","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0125","doi-asserted-by":"crossref","first-page":"29461","DOI":"10.1074\/jbc.M804103200","article-title":"Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors","volume":"283","author":"Noberini","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0130","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.molimm.2007.09.019","article-title":"EphA and ephrin-A proteins regulate integrin-mediated T lymphocyte interactions","volume":"45","author":"Sharfe","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0135","doi-asserted-by":"crossref","first-page":"36505","DOI":"10.1074\/jbc.M706340200","article-title":"Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition","volume":"282","author":"Chrencik","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.str.2005.11.011","article-title":"Structure and thermodynamic characterization of the EphB4\/Ephrin-B2 antagonist peptide complex reveals the determinants for receptor specificity","volume":"14","author":"Chrencik","year":"2006","journal-title":"Structure"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0145","doi-asserted-by":"crossref","first-page":"241","DOI":"10.2967\/jnumed.110.081943","article-title":"In vivo small-animal PET\/CT of EphB4 receptors using 64Cu-labeled peptide","volume":"52","author":"Xiong","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0150","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1016\/j.biomaterials.2011.04.070","article-title":"Peptide-conjugated polymeric micellar nanoparticles for Dual SPECT and optical imaging of EphB4 receptors in prostate cancer xenografts","volume":"32","author":"Zhang","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0155","doi-asserted-by":"crossref","first-page":"3994","DOI":"10.1158\/0008-5472.CAN-07-0525","article-title":"Paradoxes of the EphB4 receptor in cancer","volume":"67","author":"Noren","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0160","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10456-010-9183-z","article-title":"The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis","volume":"13","author":"Martiny-Baron","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0165","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nature09002","article-title":"Ephrin-B2 controls VEGF-induced angiogenesis and lymphangiogenesis","volume":"465","author":"Wang","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0170","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1182\/blood-2008-12-192294","article-title":"EphrinB reverse signaling contributes to endothelial and mural cell assembly into vascular structures","volume":"114","author":"Salvucci","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0175","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1021\/bi061661x","article-title":"Cupredoxin\u2013cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth","volume":"46","author":"Chaudhari","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0180","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1002\/prot.22785","article-title":"Can self-inhibitory peptides be derived from the interfaces of globular protein\u2013protein interactions?","volume":"78","author":"London","year":"2010","journal-title":"Proteins"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0185","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00109-005-0705-x","article-title":"Targeting protein\u2013protein interactions for cancer therapy","volume":"83","author":"Fry","year":"2005","journal-title":"J Mol Med"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio0306-112","article-title":"Between a rock and a hard place?","volume":"2","author":"Whitty","year":"2006","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0195","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1038\/nature06526","article-title":"Reaching for high-hanging fruit in drug discovery at protein\u2013protein interfaces","volume":"450","author":"Wells","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0200","doi-asserted-by":"crossref","first-page":"29473","DOI":"10.1074\/jbc.M804114200","article-title":"Crystal structure and NMR binding reveal that two small molecule antagonists target the high affinity ephrin-binding channel of the EphA4 receptor","volume":"283","author":"Qin","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0325","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1747-0285.2011.01199.x","article-title":"A disalicylic acid-furanyl derivative inhibits ephrin binding to a subset of Eph receptors","volume":"78","author":"Noberini","year":"2011","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0210","doi-asserted-by":"crossref","first-page":"e18128","DOI":"10.1371\/journal.pone.0018128","article-title":"Lithocholic acid is an Eph\u2013ephrin ligand interfering with Eph-kinase activation","volume":"6","author":"Giorgio","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0330","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.phrs.2011.06.008","article-title":"Polyphenol-rich botanicals used as food supplements interfere with the EphA2\u2013ephrin-A1 system","volume":"64","author":"Mohamed","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0220","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jnutbio.2006.07.004","article-title":"Green tea catechin inhibits ephrin-A1-mediated cell migration and angiogenesis of human umbilical vein endothelial cells","volume":"18","author":"Tang","year":"2007","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0225","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/nbt1358","article-title":"A quantitative analysis of kinase inhibitor selectivity","volume":"26","author":"Karaman","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0230","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/bioinformatics\/btp650","article-title":"Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis","volume":"26","author":"Huang","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0235","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nrc2559","article-title":"Targeting cancer with small molecule kinase inhibitors","volume":"9","author":"Zhang","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0240","doi-asserted-by":"crossref","first-page":"4467","DOI":"10.1016\/j.bmcl.2009.05.029","article-title":"Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors","volume":"19","author":"Choi","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0245","doi-asserted-by":"crossref","first-page":"6122","DOI":"10.1016\/j.bmcl.2009.09.010","article-title":"Structure-activity relationship study of EphB3 receptor tyrosine kinase inhibitors","volume":"19","author":"Qiao","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0250","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1016\/j.bmcl.2008.04.015","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 1: structure-based design and optimization of a series of 2,4-bis-anilinopyrimidines","volume":"18","author":"Bardelle","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0255","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/j.bmcl.2011.03.009","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 4: discovery and optimization of a benzylic alcohol series","volume":"21","author":"Barlaam","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0260","doi-asserted-by":"crossref","first-page":"6242","DOI":"10.1016\/j.bmcl.2010.08.100","article-title":"Inhibitors of the tyrosine kinase EphB4. Part 3: identification of non-benzodioxole-based kinase inhibitors","volume":"20","author":"Bardelle","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0265","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.bmcl.2006.09.050","article-title":"Design and effective synthesis of novel templates, 3,7-diphenyl-4-amino-thieno and furo-[3,2-c]pyridines as protein kinase inhibitors and in vitro evaluation targeting angiogenetic kinases","volume":"17","author":"Miyazaki","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0270","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1016\/j.bmcl.2009.10.037","article-title":"Imidazo[1,2-a]pyrazine diaryl ureas: inhibitors of the receptor tyrosine kinase EphB4","volume":"19","author":"Mitchell","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0275","doi-asserted-by":"crossref","first-page":"6433","DOI":"10.1021\/jm9009444","article-title":"Structure-based optimization of potent and selective inhibitors of the tyrosine kinase erythropoietin producing human hepatocellular carcinoma receptor B4 (EphB4)","volume":"52","author":"Lafleur","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0280","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/cmdc.201000085","article-title":"High-throughput virtual screening using quantum mechanical probes: discovery of selective kinase inhibitors","volume":"5","author":"Zhou","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0285","article-title":"Discovery of LY2457546: a multi-targeted anti-angiogenic kinase inhibitor with a novel spectrum of activity and exquisite potency in the acute myelogenous leukemia-Flt-3-internal tandem duplication mutant human tumor xenograft model","author":"Burkholder","year":"2011","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0290","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1073\/pnas.0511292103","article-title":"An efficient rapid system for profiling the cellular activities of molecular libraries","volume":"103","author":"Melnick","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0295","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1042\/BJ20070797","article-title":"The selectivity of protein kinase inhibitors: a further update","volume":"408","author":"Bain","year":"2007","journal-title":"Biochem J"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0300","doi-asserted-by":"crossref","first-page":"jc6","DOI":"10.1126\/scisignal.3138jc6","article-title":"Receptor tyrosine kinase transmembrane domain interactions: potential target for interceptor therapy","volume":"3","author":"Kajanajmudeen","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0305","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.mencom.2010.09.007","article-title":"Novel fragment-like inhibitors of EphA2 obtained by experimental screening and modelling","volume":"20","author":"Stroylov","year":"2010","journal-title":"Mendeleev Commun"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0310","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.bjc.6604676","article-title":"Effects of dasatinib on EphA2 receptor tyrosine kinase activity and downstream signalling in pancreatic cancer","volume":"99","author":"Chang","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0315","doi-asserted-by":"crossref","first-page":"3713","DOI":"10.1158\/1078-0432.CCR-06-2590","article-title":"Inhibition of the T790M gatekeeper mutant of the epidermal growth factor receptor by EXEL-7647","volume":"13","author":"Gendreau","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcdb.2011.10.023_bib0320","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.chembiol.2006.05.008","article-title":"MASPIT: three-hybrid trap for quantitative proteome fingerprinting of small molecule-protein interactions in mammalian cells","volume":"13","author":"Caligiuri","year":"2006","journal-title":"Chem Biol"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952111002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952111002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:57:28Z","timestamp":1543453048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952111002114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S1084952111002114"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2011.10.023","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}